DNA31
DNA31 is a potent RNA polymerase inhibitor[1].
Product Specifications
UNSPSC
12352005
Target
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/dna31.html
Purity
96.21
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1C2=C(O[C@@]1(O/C=C\[C@]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@@H](O)[C@@H](C)/C=C/C=C(C)/C3=O)C)O)C)OC(C)=O)C)([H])OC)C)C(C)=C(O)C4=C2C(C(OC5=CC(N6CCC(N)CC6)=C7)=C(N3)C4=O)=NC5=C7O
Molecular Formula
C48H58N4O13
Molecular Weight
898.99
References & Citations
[1]Staben LR, et al. Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugates. Nat Chem. 2016 Dec;8 (12) :1112-1119.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-128917/DNA31-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-128917/DNA31-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[845626-57-5]
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6465308-01 0.2 mL
BID (Ser61) (BH3-interacting Domain Death Agonist, p22 BID) (APC)
Ask
View Details 
MBS6465308-02 5x 0.2 mL
BID (Ser61) (BH3-interacting Domain Death Agonist, p22 BID) (APC)
Ask
View Details 
BNC941482-100 1x 100 µL
S100A4 (Marker of Tumor Metastasis) (S100A4/1482), CF594 conjugate, 0.1mg/mL
Ask
View Details